Navigating the World of Insulin: An Update on Types, Uses, and Considerations

Program Description

Despite the availability of treatments, diabetes continues to be the eighth leading cause of death in the United States. Characterized by high blood sugar levels, diabetes is a public health threat due to its increased risk for both microvascular and macrovascular complications. The first line of treatment typically includes lifestyle modifications combined with oral medications, such as metformin, but many patients struggle to achieve optimal blood sugar control. Diabetes is a progressive disease that often requires insulin replacement therapy to effectively manage hyperglycemia. Pharmacists play a crucial role in identifying patients who may not be adequately managed on oral therapy or could benefit from insulin therapies. This activity will explore the role of insulin replacement therapy in managing both type 1 and type 2 diabetes, review different insulin therapies, and the importance of patient education.

Target Audience: Community pharmacists and health system pharmacists

Type of Activity: Knowledge
Release date: May 5, 2025
Expiration date: May 5, 2026
Learner level: Foundational
Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Recognize the various types of insulin and distinguishing factors between types
• Discuss how to safely add insulin to non-insulin agents
• Review an insulin regimen based on individual patient factors

Pharmacy Times Continuing Education^™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-25-118-H01-P.

The activity is available for CE credit through May 5, 2026.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Jennifer L. Rosselli, PharmD, BCACP, BC-ADM, CDCES, has the following relevant financial relationships with commercial interests to disclose:

Consultant: Medtronic, Inc.

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBACrissy Wilson; Susan Pordon; Brianna Winters; Chloe Taccetta, and Rebecca Green have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times® Editorial Staff— Aislinn Antrim

At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms